First human tests begin for new inhaled medication
NCT ID NCT07439419
Summary
This early-stage study tested the safety of an experimental inhaled medication called DBM-1152A in healthy Chinese adults. Twenty participants received either the drug or a placebo through a nebulizer once daily for seven days. Researchers monitored for side effects and measured how the drug moved through the body to determine safe dosage levels for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.